Who owns IBRX?
Institutional ownership of ImmunityBio Inc. from Form 13F, Q2 2026
404 institutional managers reported holding ImmunityBio Inc. (IBRX) in Form 13F filings for Q2 2026, with 202,098,657 shares worth $1.8B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 22,261,237 shares (+12.5%). 57 opened new positions and 45 sold out.
- Funds holding
- 404
- Value held
- $1.8B
- New / sold out
- 57 / 45
- Net shares, same filers
- +12.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IBRX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $298M | 16.9% | 34,083,262 | Added |
| State Street Corp | $187M | 10.6% | 21,398,438 | Added |
| Vanguard Portfolio Management LLC | $156M | 8.8% | 17,863,911 | Added |
| Vanguard Capital Management LLC | $137M | 7.8% | 15,691,579 | Added |
| D. E. Shaw & Co., Inc. | $101M | 5.7% | 11,551,019 | Trimmed |
| Two Sigma Investments, LP | $97.2M | 5.5% | 11,097,106 | Added |
| Geode Capital Management, LLC | $86.2M | 4.9% | 9,847,896 | Added |
| Millennium Management LLC | $48.9M | 2.8% | 5,579,793 | Added |
| Northern Trust Corp | $31.2M | 1.8% | 3,565,248 | Added |
| Morgan Stanley | $30.1M | 1.7% | 3,432,678 | Trimmed |
| Goldman Sachs Group Inc | $28.3M | 1.6% | 3,234,277 | Unchanged |
| UBS Group AG | $28.0M | 1.6% | 3,195,728 | Added |
| Charles Schwab Investment Management Inc | $25.3M | 1.4% | 2,888,607 | Added |
| Woodline Partners LP | $21.9M | 1.2% | 2,500,189 | Trimmed |
| SEB Asset Management AB | $21.4M | 1.2% | 2,447,150 | Unchanged |
| Vanguard Fiduciary Trust Co | $21.1M | 1.2% | 2,412,338 | Added |
| Bank of America Corp | $19.1M | 1.1% | 2,184,489 | Trimmed |
| Voloridge Investment Management, LLC | $15.1M | 0.9% | 1,721,902 | Trimmed |
| Federated Hermes, Inc. | $15.0M | 0.8% | 1,713,200 | Added |
| Royal Bank of Canada | $13.5M | 0.8% | 1,542,717 | Added |
| JPMorgan Chase & Co | $12.9M | 0.7% | 1,450,180 | Trimmed |
| Bank of New York Mellon Corp | $11.5M | 0.7% | 1,314,760 | Added |
| First Trust Advisors LP | $10.6M | 0.6% | 1,214,667 | New |
| Cetera Investment Advisers | $10.0M | 0.6% | 1,140,476 | Added |
| Sound Capital Solutions LLC | $9.8M | 0.6% | 1,120,808 | First report |
Share of 13F holdings is each fund's shares as a share of the 202,098,657 IBRX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$67.7M
- Two Sigma Investments, LP Added+$58.8M
- Millennium Management LLC Added+$36.4M
- State Street Corp Added+$32.3M
- Geode Capital Management, LLC Added+$15.9M
- Vanguard Portfolio Management LLC Added+$13.5M
- First Trust Advisors LP New+$10.6M
- Northern Trust Corp Added+$9.3M
- Renaissance Technologies LLC New+$9.0M
- Osaic Holdings, Inc. Added+$6.8M
Biggest sellers in Q2 2026
- HRT Financial LP Sold out-$30.1M
- Private Advisor Group, LLC Trimmed-$13.0M
- Voloridge Investment Management, LLC Trimmed-$10.6M
- Barclays PLC Trimmed-$10.2M
- Susquehanna International Group, LLP Trimmed-$9.7M
- D. E. Shaw & Co., Inc. Trimmed-$8.9M
- Woodline Partners LP Trimmed-$8.3M
- Jane Street Group, LLC Trimmed-$5.5M
- Voleon Capital Management LP Trimmed-$5.3M
- National Bank of Canada Trimmed-$5.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $360M and sold $157M; 139 added and 98 trimmed.
Questions about IBRX ownership
- Who owns IBRX stock?
- 404 institutional investment managers reported IBRX positions in their Form 13F filings for Q2 2026, holding 202,098,657 shares worth $1.8B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling IBRX?
- In Q2 2026, 57 managers opened new IBRX positions, 139 added, 98 trimmed and 45 sold out. Managers that filed in both quarters added a net 22,261,237 shares.
- How current is this IBRX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IBRX by CUSIP. Options are left out. IBRX news and filings · IBRX insider trades · Top funds